Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Evofem Biosciences Inc
(OP:
EVFM
)
0.0095
+0.0004 (+4.40%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
427,842
Open
0.0091
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0091
Today's Range
0.0091 - 0.0102
52wk Range
0.0060 - 0.2260
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Releases Shareholder Update, Plans for Remainder of 2024
October 03, 2024
Via
Investor Brand Network
Aditxt Delivers Shareholder Update and 2024 Year-End Plan
October 03, 2024
From
Aditxt, Inc.
Via
Business Wire
Performance
YTD
-84.14%
-84.14%
1 Month
+7.95%
+7.95%
3 Month
-13.64%
-13.64%
6 Month
-52.50%
-52.50%
1 Year
-92.69%
-92.69%
More News
Read More
InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Acquisition Target Files Preliminary Proxy Seeking Stockholder Approval
September 24, 2024
Via
Investor Brand Network
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
September 24, 2024
From
Aditxt, Inc.
Via
Business Wire
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q2 2024
August 14, 2024
Via
InvestorPlace
InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test
September 20, 2024
Via
Investor Brand Network
Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
September 20, 2024
From
Aditxt, Inc.
Via
Business Wire
Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024
September 09, 2024
From
Aditxt, Inc.
Via
Business Wire
Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
August 29, 2024
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company Update
August 14, 2024
Via
Investor Brand Network
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
August 02, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
OTCQB Venture Virtual Investor Conference Agenda Announced for August 1st
July 30, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st
July 25, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Inks Middle East License, Supply Agreement for Proprietary Birth Control Product
July 23, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX), Evofem Biosciences (EVFM) Announce Amended, Restates Merger Agreement
July 17, 2024
Via
Investor Brand Network
Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing
July 17, 2024
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX), Evofem Biosciences (EVFM) Announce Market Partnership with Hello Alpha
June 27, 2024
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.